OpenEvidence

Launched during the Mayo Clinic Platform Accelerate program, backed by Sequoia, and an official Content Partner of the New England Journal of Medicine, OpenEvidence is the world’s leading medical information platform.

AI Agents
Clinical Trials
Digital Health
Healthtech
Healthcare & Life Sciences

Round

Industry

Raise timeline

Sep 24, 2026
$250M
Series C+
Led by Andreessen Horowitz
- Andreessen Horowitz
- Byers Capital
Article coming soon.

Pricing

Research OpenEvidence — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Get started

Features

Access to core AI adoption signals
3–5 curated slices per week
30–60 companies / week
AI Adoption Score
Deal-ready insights (why + pitch angle)
Basic filters (recency, slice, score)
CSV export

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Get started

Features

Everything in Growth, plus:
Full access to all slices
60–120 companies / week
Higher-frequency signal updates
Priority / early signals (before Growth)
Advanced filters (industry, size, use case)
Deeper company insights
Faster export + bulk workflows

Act on this raise

See if OpenEvidence is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

Start free All funding Visit website